RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gland Pharma Stock

Gland Pharma ROA 2025

Gland Pharma ROA

0

Ticker

GLAND.NS

ISIN

INE068V01023

In 2025, Gland Pharma's return on assets (ROA) was 0, a -100% increase from the 0.09 ROA in the previous year.

Gland Pharma Aktienanalyse

What does Gland Pharma do?

Gland Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Gland Pharma's Return on Assets (ROA)

Gland Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Gland Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Gland Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Gland Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Gland Pharma stock

What is the Return on Assets (ROA) of Gland Pharma this year?

The Return on Assets (ROA) of Gland Pharma is 0 undefined this year.

What was the ROA of Gland Pharma compared to the previous year?

The ROA of Gland Pharma has increased by -100% compared to the previous year.

What consequences do high ROA have for investors of Gland Pharma?

A high ROA is advantageous for investors of Gland Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Gland Pharma?

A low ROA can be unfavorable for investors of Gland Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Gland Pharma affect the company?

An increase in ROA of Gland Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Gland Pharma impact the company?

A reduction in the ROA of Gland Pharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Gland Pharma?

Some factors that can influence the ROA of Gland Pharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Gland Pharma important for investors?

The ROA of Gland Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Gland Pharma take to improve ROA?

To improve ROA, Gland Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Gland Pharma pay?

Over the past 12 months, Gland Pharma paid a dividend of 18 INR . This corresponds to a dividend yield of about 0.92 %. For the coming 12 months, Gland Pharma is expected to pay a dividend of 18 INR.

What is the dividend yield of Gland Pharma?

The current dividend yield of Gland Pharma is 0.92 %.

When does Gland Pharma pay dividends?

Gland Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gland Pharma?

Gland Pharma paid dividends every year for the past 0 years.

What is the dividend of Gland Pharma?

For the upcoming 12 months, dividends amounting to 18 INR are expected. This corresponds to a dividend yield of 0.92 %.

In which sector is Gland Pharma located?

Gland Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gland Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gland Pharma from 9/27/2025 amounting to 18 INR, you needed to have the stock in your portfolio before the ex-date on 8/14/2025.

When did Gland Pharma pay the last dividend?

The last dividend was paid out on 9/27/2025.

What was the dividend of Gland Pharma in the year 2024?

In the year 2024, Gland Pharma distributed 20 INR as dividends.

In which currency does Gland Pharma pay out the dividend?

The dividends of Gland Pharma are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gland Pharma

Our stock analysis for Gland Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gland Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.